CervoMed Inc. Debt Conversion, Original Debt, Amount
CervoMed Inc. (CRVO) reported Debt Conversion, Original Debt, Amount of $700.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2018-04-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2018-04-02
- CervoMed Inc. debt conversion, original debt, amount for the quarter ending 2016-12-31 was $5.00K.
- CervoMed Inc. debt conversion, original debt, amount for the quarter ending 2016-09-30 was $0.00.
- CervoMed Inc. debt conversion, original debt, amount for the quarter ending 2016-06-30 was $0.00.
- CervoMed Inc. debt conversion, original debt, amount for the quarter ending 2016-03-31 was $695.00K.
- CervoMed Inc. debt conversion, original debt, amount for fiscal 2016 was $700.00K, a 96.34% decline from fiscal 2015.
- CervoMed Inc. debt conversion, original debt, amount for fiscal 2015 was $19.10M.
| Period end | Debt Conversion, Original Debt, Amount 0 month | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $5.00K derived: sum of 2 quarters · filed 2018-04-02 | $5.00K derived: sum of 3 quarters · filed 2018-04-02 | $700.00K 10-K · filed 2018-04-02 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $0.00 derived: sum of 2 quarters · filed 2016-11-14 | $695.00K 10-Q · filed 2016-11-14 | ||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $695.00K 10-Q · filed 2016-08-15 | |||
| 2016-03-31 | $695.00K 10-Q · filed 2016-05-16 | ||||
| 2015-12-31 | $19.10M 10-K · filed 2017-03-31 | ||||
| 2014-06-06 | $1.05M 10-Q · filed 2014-11-12 | ||||
| 2014-05-21 | $500.00K 10-Q · filed 2014-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |